Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities. [electronic resource]
Producer: 20170705Description: 269-272 p. digitalISSN:- 1678-9849
- Aged
- Antiprotozoal Agents -- administration & dosage
- Female
- Humans
- Injections, Intralesional
- Leishmaniasis, Cutaneous -- drug therapy
- Male
- Meglumine -- administration & dosage
- Meglumine Antimoniate
- Middle Aged
- Organometallic Compounds -- administration & dosage
- Severity of Illness Index
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.